Toxicological Evaluation of Acyl Glucuronides of Nonsteroidal Anti-Inflammatory Drugs Using Human Embryonic Kidney 293 Cells Stably Expressing Human UDP-Glucuronosyltransferase and Human Hepatocytes

The chemical reactivity of acyl glucuronide (AG) has been thought to be associated with the toxic properties of drugs containing carboxylic acid moieties, but there has been no direct evidence that AG formation was related to the toxicity. In the present study, the cytotoxicity and genotoxicity of AGs were investigated. Human embryonic kidney (HEK) 293 cells stably expressing UDP-glucuronosyltransferase (UGT) 1A3 (HEK/UGT1A3) were constructed to assess the cytotoxicity of AGs, and HEK/UGT1A4 cells were also used as a negative reference. After exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) such as naproxen (1 mM), diclofenac (0.1 mM), ketoprofen (1 mM), or ibuprofen (1 mM) for 24 h, HEK/UGT1A3 cells produced AG in a time-dependent manner. However, HEK/UGT1A4 cells hardly produced AG. The cytotoxicity of HEK/UGT1A3 cells was not increased compared with that of HEK/UGT1A4 cells. In addition, the AG formed in NSAID-treated human hepatocytes was decreased from one-third to one-ninth by treatment with (−)-borneol, an inhibitor of acyl glucuronidation, but the cytotoxicity was increased. These results indicated that AG formation reflected the detoxification process in human hepatocytes. Furthermore, the possibility of genotoxicity from the AG formed in NSAID-treated HEK/UGT cells was investigated by the comet assay, and DNA damage was not detected in any HEK/UGT cell lines. In conclusion, the in vitro cytotoxic and genotoxic effects of the AGs of NSAIDs were investigated and AG was not found to be a causal factor in the toxicity.

[1]  K. Ishak,et al.  Diclofenac‐associated hepatotoxicity: Analysis of 180 cases reported to the food and drug administration as adverse reactions , 1995, Hepatology.

[2]  J. Weekley,et al.  Bioactivation of carboxylic acid compounds by UDP-Glucuronosyltransferases to DNA-damaging intermediates: role of glycoxidation and oxidative stress in genotoxicity. , 2006, Chemical research in toxicology.

[3]  H. Zimmerman,et al.  Idiosyncratic liver toxicity of nonsteroidal antiinflammatory drugs: molecular mechanisms and pathology. , 1995, Critical reviews in toxicology.

[4]  M. Pirmohamed,et al.  Idiosyncratic Drug Reactions , 1996 .

[5]  T. Baillie,et al.  Roles of human hepatic cytochrome P450s 2C9 and 3A4 in the metabolic activation of diclofenac. , 1999, Chemical research in toxicology.

[6]  J. Ritter.  Roles of glucuronidation and UDP-glucuronosyltransferases in xenobiotic bioactivation reactions. , 2000, Chemico-biological interactions.

[7]  J. Beijnen,et al.  Hepatic Clearance of Reactive Glucuronide Metabolites of Diclofenac in the Mouse Is Dependent on Multiple ATP-Binding Cassette Efflux Transporters , 2010, Molecular Pharmacology.

[8]  K. Maeda,et al.  Contribution of OATP2 (OATP1B1) and OATP8 (OATP1B3) to the Hepatic Uptake of Pitavastatin in Humans , 2004, Journal of Pharmacology and Experimental Therapeutics.

[9]  T. Vree,et al.  Pharmacokinetics of naproxen, its metabolite O‐desmethylnaproxen, and their acyl glucuronides in humans , 1993, Biopharmaceutics & drug disposition.

[10]  M. Pirmohamed,et al.  Idiosyncratic drug reactions. Metabolic bioactivation as a pathogenic mechanism. , 1996, Clinical pharmacokinetics.

[11]  E. Plater.  [Hepatic clearance]. , 1961, Archivos argentinos de pediatria.

[12]  Jill P. Smith,et al.  Ibuprofen-induced hepatotoxicity in patients with chronic hepatitis c: a case series , 1998, American Journal of Gastroenterology.

[13]  T. Nishiyama,et al.  Cooperation of NAD(P)H:quinone oxidoreductase 1 and UDP-glucuronosyltransferases reduces menadione cytotoxicity in HEK293 cells. , 2010, Biochemical and biophysical research communications.

[14]  M Schwab,et al.  UDP‐Glucuronosyltransferase (UGT) Polymorphisms Affect Atorvastatin Lactonization In Vitro and In Vivo , 2010, Clinical pharmacology and therapeutics.

[15]  T. Horie,et al.  Naproxen-induced oxidative stress in the isolated perfused rat liver. , 2006, Chemico-biological interactions.

[16]  J. G. Kenna,et al.  Immunochemical identification of mouse hepatic protein adducts derived from the nonsteroidal anti-inflammatory drugs diclofenac, sulindac, and ibuprofen. , 1997, Chemical research in toxicology.

[17]  A. Walker.  Quantitative studies of the risk of serious hepatic injury in persons using nonsteroidal antiinflammatory drugs. , 1997, Arthritis and rheumatism.

[18]  F. Jamali,et al.  Pharmacokinetics of ketoprofen enantiomers in young and elderly arthritic patients following single and multiple doses. , 1988, Journal of pharmaceutical sciences.

[19]  M. Bailey,et al.  Acyl glucuronide reactivity in perspective: biological consequences. , 2003, Chemico-biological interactions.

[20]  J. Miners,et al.  Critical Roles of Residues 36 and 40 in the Phenol and Tertiary Amine Aglycone Substrate Selectivities of UDP-Glucuronosyltransferases 1A3 and 1A4 , 2007, Molecular Pharmacology.

[21]  S. Ikushiro,et al.  Effects of Coexpression of UGT1A9 on Enzymatic Activities of Human UGT1A Isoforms , 2007, Drug Metabolism and Disposition.

[22]  V. Armstrong,et al.  Acyl Glucuronide Drug Metabolites: Toxicological and Analytical Implications , 2003, Therapeutic drug monitoring.

[23]  R. Fujiwara,et al.  Interactions between Human UGT1A1, UGT1A4, and UGT1A6 Affect Their Enzymatic Activities , 2007, Drug Metabolism and Disposition.

[24]  T. Baillie,et al.  Extrapolation of Diclofenac Clearance from in Vitro Microsomal Metabolism Data: Role of Acyl Glucuronidation and Sequential Oxidative Metabolism of the Acyl Glucuronide , 2002, Journal of Pharmacology and Experimental Therapeutics.

[25]  U. Boelsterli,et al.  Diclofenac acyl glucuronide, a major biliary metabolite, is directly involved in small intestinal injury in rats. , 1998, Gastroenterology.

[26]  P C Smith,et al.  Disposition and reactivity of ibuprofen and ibufenac acyl glucuronides in vivo in the rhesus monkey and in vitro with human serum albumin. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[27]  R. Fujiwara,et al.  N-Glycosylation plays a role in protein folding of human UGT1A9. , 2010, Biochemical pharmacology.

[28]  U. Boelsterli,et al.  Diclofenac-induced liver injury: a paradigm of idiosyncratic drug toxicity. , 2003, Toxicology and applied pharmacology.

[29]  J. Miners,et al.  Carboxylic acid drug-induced DNA nicking in HEK293 cells expressing human UDP-glucuronosyltransferases: role of acyl glucuronide metabolites and glycation pathways. , 2007, Chemical research in toxicology.

[30]  A. Martelli,et al.  Genotoxicity and carcinogenicity studies of analgesics, anti-inflammatory drugs and antipyretics. , 2009, Pharmacological research.

[31]  T. Vree,et al.  The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine. , 1993, British journal of clinical pharmacology.

[32]  M. Bailey,et al.  Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system. , 1998, Chemico-biological interactions.

[33]  M. Cuthbert.  Section 4 Adverse reactions to non-steroidal antirheumatic drugs , 1974 .

[34]  D. Keppler,et al.  Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. , 1999, European journal of biochemistry.

[35]  R. Tice,et al.  A simple technique for quantitation of low levels of DNA damage in individual cells. , 1988, Experimental cell research.

[36]  C. King,et al.  Glucuronidation of carboxylic acid containing compounds by UDP-glucuronosyltransferase isoforms. , 2004, Archives of biochemistry and biophysics.

[37]  D. Frisbie,et al.  Nonsteroidal antiinflammatory drugs. , 1981, Delaware medical journal.

[38]  P. A. Rea,et al.  Transport of amphipathic anions by human multidrug resistance protein 3. , 2000, Cancer research.

[39]  S Kettle,et al.  Mechanistically-based Human Hazard Assessment of Peroxisome Proliferator-induced Hepatocarcinogenesis , 1994, Human & experimental toxicology.

[40]  P. Burcham,et al.  Genotoxicity of acyl glucuronide metabolites formed from clofibric acid and gemfibrozil: a novel role for phase-II-mediated bioactivation in the hepatocarcinogenicity of the parent aglycones? , 1997, Toxicology and applied pharmacology.

[41]  K. Kohn.  Principles and practice of DNA filter elution. , 1991, Pharmacology & therapeutics.